MTAP and neoplasm: Hemizygous MTAP loss was present in 5 of 38 (13.2%) cases, while in 5 (13.2%) cases MTAP deletion status could not be confidently interpreted (Figure 1), likely due to a combination of MTAP deletion sizes under the resolution of the CMA gene region probe coverage or lower tumor content (Figure S2).